{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:27:43Z","timestamp":1787725663859,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/jcp.0b013e3181de80f8","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T04:28:32Z","timestamp":1273033712000},"page":"339-341","source":"Crossref","is-referenced-by-count":6,"title":["Mania Associated With Mefloquine Prophylaxis"],"prefix":"10.1097","volume":"30","author":[{"given":"Silvia","family":"Yelmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando L.","family":"Morera-Fumero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Renshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Gracia-Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1475-2875-5-74","article-title":"Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report.","volume":"5","author":"Tran","year":"2006","journal-title":"Malar J"},{"key":"R2-25-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2458-2-6","article-title":"Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?","volume":"2","author":"Croft","year":"2002","journal-title":"BMC Public Health"},{"key":"R3-25-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-199911010-00001","article-title":"Neuropsychiatric adverse effects of mefloquine-what do we know and what should we do?","volume":"11","author":"Nosten","year":"1999","journal-title":"CNS Drugs"},{"key":"R4-25-20210128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-3156.1998.00163.x","article-title":"Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study.","volume":"3","author":"Ronn","year":"1998","journal-title":"Trop Med Int Health"},{"issue":"4","key":"R5-25-20210128","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.jcp.0000169619.07325.ff","article-title":"First-time diagnosis of severe depression: induced by mefloquine?","volume":"25","author":"Whitworth","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R6-25-20210128","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/SMJ.0b013e318167a9e2","article-title":"Psychotic mania associated with mefloquine in a bipolar patient.","volume":"101","author":"Brumbaugh","year":"2008","journal-title":"South Med J"},{"key":"R7-25-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.clpt.2006.07.003","article-title":"MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.","volume":"80","author":"Aarnoudse","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R8-25-20210128","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0196-0644(96)70206-8","article-title":"Mefloquine-induced psychosis.","volume":"27","author":"Piening","year":"1996","journal-title":"Ann Emerg Med"},{"key":"R9-25-20210128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tmaid.2008.12.004","article-title":"Mefloquine neurotoxicity: a literature review.","volume":"7","author":"Toovey","year":"2009","journal-title":"Travel Med Infect Dis"},{"key":"R10-25-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2310\/7060.2000.00002","article-title":"Neuropsychiatric problems in 2,500 long-term young travellers to the tropics.","volume":"7","author":"Potasman","year":"2000","journal-title":"J Travel Med"},{"key":"R11-25-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2310\/7060.2000.00069","article-title":"Neuropsychiatric events and travel: do antimalarial play a role?","volume":"7","author":"Schlagenhauf","year":"2000","journal-title":"J Travel Med"},{"key":"R12-25-20210128","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0035-9203(93)90037-Q","article-title":"Neuropsychiatric side effects of mefloquine in Africans.","volume":"87","author":"Sowunmi","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R13-25-20210128","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1179\/000349804225021262","article-title":"The relationship between body weight and tolerance to mefloquine prophylaxis in non-immune adults: results of a questionnaire-based study.","volume":"98","author":"Ollivier","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"R14-25-20210128","first-page":"67","article-title":"Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: a propos of 2 cases.","volume":"26","author":"Lebain","year":"2000","journal-title":"Encephale"},{"key":"R15-25-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","article-title":"Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.","volume":"75","author":"Marzolini","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R16-25-20210128","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.bjp.0703638","article-title":"The antimalarial agent mefloquine inhibits ATP-sensitive-K-channels.","volume":"131","author":"Gribble","year":"2000","journal-title":"Br J Pharmacol"},{"key":"R19-25-20210128","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/322694","article-title":"Atovaquone-proguanil versus mefloquine for malaria prophylaxis in non-immune travelers: results from a randomized double-blind study.","volume":"33","author":"Overbosch","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201006000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:17:33Z","timestamp":1786040253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201006000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181de80f8","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}